Recombinant Human DIABLO Protein，His

The DIABLO protein, also known as Smac (Second Mitochondria-derived Activator of Caspases), has emerged as a critical component in the study of apoptosis, particularly in the context of cancer biology. Discovered as a mitochondrial protein released into the cytosol during apoptosis, DIABLO acts as a potent inhibitor of inhibitor of apoptosis proteins (IAPs), thereby promoting the activation of caspases and facilitating programmed cell death. Understanding the regulatory mechanisms of DIABLO and its interactions with IAPs provides insights into the dysfunctional apoptotic pathways often observed in cancer cells, which evade cell death and contribute to tumor progression and resistance to therapies. Researchers are interested in the potential of DIABLO as a therapeutic target or biomarker due to its pivotal role in modulating apoptosis. Additionally, studies investigating the structural characteristics of DIABLO, its signaling pathways, and its functional role in various cellular conditions have significant implications for developing innovative cancer treatments, including the design of DIABLO-based drugs or mimetics that can restore apoptotic sensitivity in resistant tumors. This growing body of research underscores the importance of DIABLO in the broader context of cancer treatment, as well as its potential applications in enhancing the efficacy of existing therapies by overcoming apoptosis resistance.